IDENTIFICATION OF NEW BIOMARKERS FOR SEVERITY, DISEASE PROGRESSION AND RESPONSE TO TREATMENT FOR COVID-19

  • Guillemin, Gilles (Primary Chief Investigator)

    Project: Research

    Project Details

    Description

    The project aims to analyse the blood samples collected at different time points (longitudinal) from patients infected with COVID-19/SARS-COV2 for more than 85 inflammatory markers to identify a new set of biomarkers for:
    1) Rapid evaluation of the severity of the diseases (level of inflammation and immune activation);
    2) Estimate the rate of progression of the disease (getting worse or improving);
    3) Response to potential treatments i.e. hydroxychloroquine, etc… (from non-responders to responder with rate of improvement).
    Short titleBiomarkers for COVID-19
    StatusFinished
    Effective start/end date1/06/201/12/20